Palisade Bio (PALI) Research & Development (2010 - 2026)
Palisade Bio (PALI) reported Research & Development of $6.0 million for Q1 2026, up 531.58% year-over-year from $950000.0 in Q1 2025, and down 2.8% quarter-over-quarter from $6.2 million in Q4 2025.
Palisade Bio (PALI) Research & Development (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 17 years of Research & Development data on file, last reported at $6.0 million in Q1 2026.
- Research & Development for Q1 2026 came in at $6.0 million, up 531.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.2 million (down 29.64% YoY), and the FY2025 annual result was $10.2 million, up 12.46% from the prior year.
- Research & Development declined to $6.0 million in Q1 2026 per PALI's latest filing, from $6.2 million in the prior quarter.
- Over five years, Research & Development peaked at $16.0 million in Q3 2024 and troughed at $362000.0 in Q4 2023.
- A 5-year average of $3.0 million and a median of $2.1 million in 2024 frame the typical range for Research & Development.
- The sharpest annual moves came in 2024 and 2025: Research & Development soared 660.46% in 2024, then plunged 91.29% in 2025.
- A 5-year view of Research & Development shows it stood at $2.3 million in 2022, then sank by 84.55% to $362000.0 in 2023, then surged by 475.69% to $2.1 million in 2024, then jumped by 196.21% to $6.2 million in 2025, then slipped by 2.8% to $6.0 million in 2026.
- Business Quant data shows PALI's Research & Development at $6.0 million in Q1 2026, $6.2 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - | 6.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 6.17 Mn |
| Sep 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 950,000.00 |
| Dec 31, 2024 | 2.08 Mn |
| Sep 30, 2024 | 16.00 Mn |
| Jun 30, 2024 | 2.63 Mn |
| Mar 31, 2024 | 2.21 Mn |
| Dec 31, 2023 | 362,000.00 |
| Sep 30, 2023 | 2.10 Mn |
| Jun 30, 2023 | 2.18 Mn |
| Mar 31, 2023 | 1.24 Mn |
| Dec 31, 2022 | 2.34 Mn |
| Sep 30, 2022 | 1.93 Mn |
| Jun 30, 2022 | 1.32 Mn |
| Mar 31, 2022 | 959,000.00 |
| Dec 31, 2021 | 800,000.00 |
| Sep 30, 2021 | 624,000.00 |
| Jun 30, 2021 | 314,000.00 |